CLX Quote, Financials, Valuation and Earnings

Colgate-Palmolive Co. has a net margin of 5.74% compared to The Clorox Co.'s net margin of 14.93%. The Clorox Co.'s return on equity of 347.62% beat Colgate-Palmolive Co.'s return on equity of 345.67%.

The Clorox Co. has a consensus price target of $122.41, signalling upside risk potential of 24.64%. On the other hand Colgate-Palmolive Co. has an analysts' consensus of $87.32 which suggests that it could grow by 8.81%. Given that The Clorox Co. has higher upside potential than Colgate-Palmolive Co., analysts believe The Clorox Co. is more attractive than Colgate-Palmolive Co..

The Clorox Co. has a beta of 0.571, which suggesting that the stock is 42.917% less volatile than S&P 500. In comparison Colgate-Palmolive Co. has a beta of 0.299, suggesting its less volatile than the S&P 500 by 70.053%.

The Clorox Co. has a quarterly dividend of $1.24 per share corresponding to a yield of 5.01%. Colgate-Palmolive Co. offers a yield of 2.57% to investors and pays a quarterly dividend of $0.52 per share. The Clorox Co. pays 75.19% of its earnings as a dividend. Colgate-Palmolive Co. pays out 56.42% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Clorox Co. quarterly revenues are $1.4B, which are smaller than Colgate-Palmolive Co. quarterly revenues of $5.1B. The Clorox Co.'s net income of $82M is lower than Colgate-Palmolive Co.'s net income of $766M. Notably, The Clorox Co.'s price-to-earnings ratio is 15.39x while Colgate-Palmolive Co.'s PE ratio is 22.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Clorox Co. is 1.80x versus 3.25x for Colgate-Palmolive Co.. Usually stocks with elevated PS ratios are considered overvalued.

Kenvue, Inc. has a net margin of 5.74% compared to The Clorox Co.'s net margin of 10.58%. The Clorox Co.'s return on equity of 347.62% beat Kenvue, Inc.'s return on equity of 13.85%.

The Clorox Co. has a consensus price target of $122.41, signalling upside risk potential of 24.64%. On the other hand Kenvue, Inc. has an analysts' consensus of $19.33 which suggests that it could grow by 12.34%. Given that The Clorox Co. has higher upside potential than Kenvue, Inc., analysts believe The Clorox Co. is more attractive than Kenvue, Inc..

The Clorox Co. has a beta of 0.571, which suggesting that the stock is 42.917% less volatile than S&P 500. In comparison Kenvue, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

The Clorox Co. has a quarterly dividend of $1.24 per share corresponding to a yield of 5.01%. Kenvue, Inc. offers a yield of 4.79% to investors and pays a quarterly dividend of $0.21 per share. The Clorox Co. pays 75.19% of its earnings as a dividend. Kenvue, Inc. pays out 150.5% of its earnings as a dividend. The Clorox Co.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Kenvue, Inc.'s is not.

The Clorox Co. quarterly revenues are $1.4B, which are smaller than Kenvue, Inc. quarterly revenues of $3.8B. The Clorox Co.'s net income of $82M is lower than Kenvue, Inc.'s net income of $398M. Notably, The Clorox Co.'s price-to-earnings ratio is 15.39x while Kenvue, Inc.'s PE ratio is 23.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Clorox Co. is 1.80x versus 2.21x for Kenvue, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Procter & Gamble Co. has a net margin of 5.74% compared to The Clorox Co.'s net margin of 21.36%. The Clorox Co.'s return on equity of 347.62% beat Procter & Gamble Co.'s return on equity of 32.18%.

The Clorox Co. has a consensus price target of $122.41, signalling upside risk potential of 24.64%. On the other hand Procter & Gamble Co. has an analysts' consensus of $168.95 which suggests that it could grow by 16.93%. Given that The Clorox Co. has higher upside potential than Procter & Gamble Co., analysts believe The Clorox Co. is more attractive than Procter & Gamble Co..

The Clorox Co. has a beta of 0.571, which suggesting that the stock is 42.917% less volatile than S&P 500. In comparison Procter & Gamble Co. has a beta of 0.387, suggesting its less volatile than the S&P 500 by 61.258%.

The Clorox Co. has a quarterly dividend of $1.24 per share corresponding to a yield of 5.01%. Procter & Gamble Co. offers a yield of 2.89% to investors and pays a quarterly dividend of $1.06 per share. The Clorox Co. pays 75.19% of its earnings as a dividend. Procter & Gamble Co. pays out 62.63% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Clorox Co. quarterly revenues are $1.4B, which are smaller than Procter & Gamble Co. quarterly revenues of $22.4B. The Clorox Co.'s net income of $82M is lower than Procter & Gamble Co.'s net income of $4.8B. Notably, The Clorox Co.'s price-to-earnings ratio is 15.39x while Procter & Gamble Co.'s PE ratio is 21.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Clorox Co. is 1.80x versus 4.16x for Procter & Gamble Co.. Usually stocks with elevated PS ratios are considered overvalued.

Solesence, Inc. has a net margin of 5.74% compared to The Clorox Co.'s net margin of -7.67%. The Clorox Co.'s return on equity of 347.62% beat Solesence, Inc.'s return on equity of 6.62%.

The Clorox Co. has a consensus price target of $122.41, signalling upside risk potential of 24.64%. On the other hand Solesence, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that The Clorox Co. has higher upside potential than Solesence, Inc., analysts believe The Clorox Co. is more attractive than Solesence, Inc..

The Clorox Co. has a beta of 0.571, which suggesting that the stock is 42.917% less volatile than S&P 500. In comparison Solesence, Inc. has a beta of 1.066, suggesting its more volatile than the S&P 500 by 6.59%.

The Clorox Co. has a quarterly dividend of $1.24 per share corresponding to a yield of 5.01%. Solesence, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Clorox Co. pays 75.19% of its earnings as a dividend. Solesence, Inc. pays out -- of its earnings as a dividend. The Clorox Co.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

The Clorox Co. quarterly revenues are $1.4B, which are larger than Solesence, Inc. quarterly revenues of $14.6M. The Clorox Co.'s net income of $82M is higher than Solesence, Inc.'s net income of -$1.1M. Notably, The Clorox Co.'s price-to-earnings ratio is 15.39x while Solesence, Inc.'s PE ratio is 135.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Clorox Co. is 1.80x versus 2.17x for Solesence, Inc.. Usually stocks with elevated PS ratios are considered overvalued.